Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
出版年份 2021 全文链接
标题
Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-01-27
DOI
10.1002/med.21760
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP
- (2020) Dongwei Kang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
- (2020) Pierre Frange et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
- (2020) Benjamin M. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
- (2020) Ting-Ting Li et al. MOLECULES
- Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1
- (2020) Yang Yang et al. BIOORGANIC CHEMISTRY
- hERG toxicity assessment: Useful guidelines for drug design
- (2020) Amanda Garrido et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors Show Low Nanomolar Inhibition of Single and Double HIV-1 Mutant Strains
- (2020) Marianna Nalli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Introduction: Drug Metabolism and Toxicology Special Issue
- (2020) F. Peter Guengerich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs
- (2020) Dongwei Kang et al. ACS Infectious Diseases
- Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors
- (2020) Xiaomei Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Applications of deuterium in medicinal chemistry
- (2019) Tracey Pirali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
- (2019) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability
- (2019) Peng Zhan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
- (2019) Boshi Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review
- (2019) BF Silva et al. HIV MEDICINE
- Molecular design opportunities presented by solvent‐exposed regions of target proteins
- (2019) Xiangyi Jiang et al. MEDICINAL RESEARCH REVIEWS
- ECG interpretation
- (2019) Rebecca R Chamley et al. EUROPEAN HEART JOURNAL
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
- (2019) Dongwei Kang et al. Acta Pharmaceutica Sinica B
- Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors
- (2019) Sheng Han et al. CHINESE CHEMICAL LETTERS
- Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities
- (2019) Ting Xiao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Arvinas’s PROTACs pass first safety and PK analysis
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles
- (2019) Sheng Han et al. ACS Infectious Diseases
- Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
- (2019) Kaijun Jin et al. Acta Pharmaceutica Sinica B
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
- (2019) Yali Sang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anthropometric measures of central adiposity are highly concordant with predictors of cardiovascular disease risk in HIV patients
- (2018) Rebeca A Beraldo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2
- (2018) Xueyi Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain
- (2018) Boshi Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1
- (2018) KaiJun Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
- (2018) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors
- (2018) Syeda Maryam Azeem et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”
- (2018) Zhongxia Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery
- (2018) Dongwei Kang et al. ACS Medicinal Chemistry Letters
- Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors
- (2018) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HUMAN CYP2A6, CYP2B6 AND CYP2E1 ATROPSELECTIVELY METABOLIZE POLYCHLORINATED BIPHENYLS TO HYDROXYLATED METABOLITES
- (2018) Eric Uwimana et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)-ones
- (2018) Maxim B. Nawrozkij et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
- (2018) Leandro Battini et al. MEDICINAL RESEARCH REVIEWS
- Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1
- (2017) Dongwei Kang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents
- (2017) Valeria Famiglini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants
- (2017) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Safe Drugs: The hERG Challenge
- (2017) Subha Kalyaanamoorthy et al. MEDICINAL RESEARCH REVIEWS
- In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals
- (2017) Vincent T. Ciavatta et al. NEUROCHEMICAL RESEARCH
- Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP
- (2017) Dongwei Kang et al. ACS Medicinal Chemistry Letters
- Current assessment of heart rate variability and QTc interval length in HIV/AIDS
- (2017) Roger C. McIntosh et al. Current Opinion in HIV and AIDS
- Novel biphenyl ester derivatives as tyrosinase inhibitors: Synthesis, crystallographic, spectral analysis and molecular docking studies
- (2017) Huey Chong Kwong et al. PLoS One
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket
- (2016) Qing Meng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
- (2016) Mônica M. Bastos et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket
- (2016) Wenmin Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
- (2016) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors
- (2016) Sergey Sergeyev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stacking with No Planarity?
- (2016) Hakan Gunaydin et al. ACS Medicinal Chemistry Letters
- A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities
- (2015) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Hybrid chemistry. Part 4: Discovery of etravirine–VRX-480773 hybrids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2015) Zheng-Yong Wan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anti-HIV diarylpyrimidine–quinolone hybrids and their mode of action
- (2015) Tian-Qi Mao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
- (2015) Zheng-Yong Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue
- (2015) Zheng-Yong Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Applications of Fluorine in Medicinal Chemistry
- (2015) Eric P. Gillis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
- (2014) Charlotte I.S. Barker et al. ADVANCED DRUG DELIVERY REVIEWS
- Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2014) Zi-Hong Yan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives
- (2014) Ye Tian et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2014) Zi-Hong Yan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach
- (2014) Liu Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization
- (2014) Zhaoqiang Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors
- (2014) Ge Meng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach
- (2014) Xiao Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2013) Xuwang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs
- (2012) Xuwang Chen et al. CURRENT MEDICINAL CHEMISTRY
- Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors
- (2012) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-(Alkyl/Aryl)Amino-6-Benzylpyrimidin-4(3H)-ones as Inhibitors of Wild-Type and Mutant HIV-1: Enantioselectivity Studies
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms
- (2012) Dongyue Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug Salt Formation via Mechanochemistry: The Case Study of Vincamine
- (2012) Dritan Hasa et al. MOLECULAR PHARMACEUTICS
- A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
- (2011) Alain Nguyen et al. AIDS
- Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs
- (2011) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and structure–activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs
- (2011) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Anti-HIV Activity of Aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as Potent Non-nucleoside Reverse Transcriptase Inhibitors
- (2011) Xiao-Dong Ma et al. ChemMedChem
- HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
- (2011) Peng Zhan et al. MEDICINAL RESEARCH REVIEWS
- Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy
- (2010) Zhao-Sen Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors
- (2010) Yong-Hong Liang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV
- (2010) Xiao-Qing Feng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Lead Optimization of Diarylpyrimidines as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase
- (2010) Zhao-Sen Zeng et al. ChemMedChem
- Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
- (2010) Bingjie Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
- (2010) Xingtao Tian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Etravirine, a Next‐Generation Nonnucleoside Reverse‐Transcriptase Inhbitor
- (2009) Leonard B. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor
- (2009) Lucy Garvey et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
- (2008) Xiao-Qing Feng et al. ChemMedChem
- The Current Status of the NNRTI Family of Antiretrovirals Used Against HIV Infection
- (2008) Silvia Martins et al. CURRENT MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started